We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
-3.59%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.41B
AUM Growth
+$279M
Cap. Flow
+$377M
Cap. Flow %
26.74%
Top 10 Hldgs %
7.59%
Holding
877
New
177
Increased
293
Reduced
202
Closed
151

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$7.53M
2
FRPT icon
Freshpet
FRPT
+$6.94M
3
S icon
SentinelOne
S
+$6.3M
4
ANET icon
Arista Networks
ANET
+$6.03M
5
CVNA icon
Carvana
CVNA
+$5.95M

Top Sells

Rank Stock Value
1
HOOD icon
Robinhood
HOOD
+$6.92M
2
F icon
Ford
F
+$6.05M
3
BIIB icon
Biogen
BIIB
+$6.03M
4
AKRO
Akero Therapeutics
AKRO
+$5.18M
5
RL icon
Ralph Lauren
RL
+$4.73M

Sector Composition

Rank Sector Weight
1 Technology 23.24%
2 Healthcare 19.71%
3 Consumer Discretionary 12.99%
4 Industrials 11.27%
5 Financials 9.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZUO
876
DELISTED
Zuora, Inc.
ZUO
-33,321
Closed -$331K
SILV
877
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
-235,705
Closed -$2.14M

Similar funds

PDT Partners's Q1 2025 Portfolio in Review

As of Q1 2025, PDT Partners held 877 positions worth $1.41B, up 25% from $1.13B the previous quarter. Its ten largest holdings account for 7.6% of the portfolio.

PDT Partners deployed $377M of net new capital in Q1 2025, opening 177 new positions and adding to 293 existing holdings. Its largest new stake was Target: 44,300 shares worth $4.62M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Robinhood, an estimated $6.92M trimmed.

  • PDT Partners's largest Q1 2025 buy was Target: 44,300 shares worth $4.62M.
  • PDT Partners added most to Moderna in Q1 2025, an estimated $7.53M increase.
  • PDT Partners's biggest Q1 2025 reduction was Robinhood, cutting an estimated $6.92M.
  • PDT Partners fully exited Biogen in Q1 2025, selling an estimated $6.03M.
  • PDT Partners's ten largest holdings make up 7.6% of its $1.41B portfolio in Q1 2025.
  • PDT Partners opened 177 new positions and closed 151 in Q1 2025.
  • PDT Partners's portfolio value rose 25% quarter-over-quarter to $1.41B.

Based on PDT Partners's 13F filing for Q1 2025, filed 15 May 2025.